Glyburide is a widely prescribed sulfonylurea medication used for the management of type 2 diabetes mellitus. The drug helps control blood glucose levels by stimulating insulin secretion from the pancreas, making it an important therapeutic option for patients who require oral antidiabetic treatment. Growing diabetes incidence worldwide, increasing awareness regarding disease management, and...
The artificial pancreas device system market is evolving through advances in automated insulin delivery and continuous glucose monitoring technologies. These systems combine glucose sensors, insulin pumps, and control algorithms to help manage blood glucose levels in people with diabetes. Growing interest in personalized diabetes care is encouraging manufacturers to improve automation,...
The Global Insulin Pens Market was valued at US$ 650.4 million in 2021 and is expected to reach US$ 1,678.4 million by 2031. The market is projected to register a CAGR of 10.2% from 2023 to 2031, driven by the increasing prevalence of diabetes, growing demand for convenient insulin administration, and continued development of advanced drug-delivery technologies....
Transthyretin Amyloidosis Treatment Market
According to the latest report published by Data Bridge Market Research, the Transthyretin Amyloidosis Treatment Market
Data Bridge Market Research analyses a growth rate in the global transthyretin amyloidosis treatment market in the forecast period 2023-2030. The expected CAGR of the global transthyretin amyloidosis treatment market...
Left Ventricular Assist Device (LVAD) Market
According to the latest report published by Data Bridge Market Research, the Left Ventricular Assist Device (LVAD) Market
The left ventricular assist device (LVAD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.6% in the...
Insulin Glargine Market
According to the latest report published by Data Bridge Market Research, the Insulin Glargine Market
insulin glargine market size was valued at USD 7.46 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 6.70% during the forecast period
The market growth is primarily driven by the increasing...
Moles Treatment Market
According to the latest report published by Data Bridge Market Research, the Moles Treatment Market
moles treatment market size was valued at USD 191.79 million in 2024 and is expected to reach USD 381.03 million by 2032, at a CAGR of 8.96% during the forecast period
The market growth for moles treatment is largely fueled by...
"
According to the latest report published by Data Bridge Market Research, the Asia-Pacific Virtual Reality Market
The Asia-Pacific virtual reality market size was valued at USD 28.46 billion in 2024 and is expected to reach USD 238.37 billion by 2032, at a CAGR of 30.43% during the forecast period
With the effectual use of technology, innovative applications and expertise,...
According to the latest report published by Data Bridge Market Research, the Congenital Hyperinsulinism Market
The global congenital hyperinsulinism market size was valued at USD 163.97 billion in 2024 and is expected to reach USD 425.22 billion by 2032, at a CAGR of 12.65% during the forecast period
This growth is driven by factors such as advancements...
"
According to the latest report published by Data Bridge Market Research, the Europe Ambulatory Infusion Pumps Market
The Europe ambulatory infusion pumps market size was valued at USD 2.27 billion in 2025 and is expected to reach USD 4.69 billion by 2033, at a CAGR of 9.5% during the forecast period.
An all inclusive Europe Ambulatory Infusion Pumps Market document...
"
According to the latest report published by Data Bridge Market Research, the Asia-Pacific Ambulatory Infusion Pumps Market
The Asia-Pacific ambulatory infusion pumps market size was valued at USD 1.29 billion in 2025 and is expected to reach USD 3.21 billion by 2033, at a CAGR of 12.1% during the forecast period.
Quality and transparency has been strictly maintained while...
"
According to the latest report published by Data Bridge Market Research, the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Lymphedema Therapy Market
The global non-steroidal anti-inflammatory drugs (NSAIDs) lymphedema therapy market size was valued at USD 56.29 Million in 2025 and is expected to reach USD 119.28 Million by 2033, at a CAGR of 9.84% during the forecast...